Albendazole
- Product NDC
- 78482-110
- 11-digit product format
- 784820110
- Labeler code
- 78482
- Product ID
- 78482-110_064c86bf-5d4d-4200-97fc-8ee09cabf000
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Albendazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mark Cuban Cost Plus Drug Company, PBC
- Application
- ANDA211117
- Marketing category
- ANDA
- Marketing start
- 2020-08-19
- Marketing end
- 0000-00-00
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 78482-110-02 | Albendazole | 2 in 1 BOTTLE | TABLET | 2 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 78482-110 | ALBENDAZOLE TABLET [MARK CUBAN COST PLUS DRUG COMPANY, PBC] | 4 | Legacy NDC, 1 package rows | 20240117_852f013f-6759-4438-83c1-8ff48133dc85.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 78482-110-02 | 78482011002 | 2 TABLET in 1 BOTTLE (78482-110-02) | 2 tablet | 2020-08-19 | 0000-00-00 | No | No | Current |